Hadassah Hospital Treatment Takes Aim at Lou Gehrig’s Disease
A new treatment tested at Hadassah Medical Center in Jerusalem and developed by an American-Israeli biotech company appears to significantly slow the progression of ALS, also known as Lou Gehrig’s disease. According to the findings of initial clinical trials published Tuesday in the medical journal JAMA Neurology, the treatment, which uses a stem cell infusion…